A case records based retrospective study for the effect of Postoperative Analgesia on Postoperative Complications of Hip Arthroplasty

注册号:

Registration number:

ITMCTR1900002518

最近更新日期:

Date of Last Refreshed on:

2019-08-11

注册时间:

Date of Registration:

2019-08-11

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

术后镇痛对髋关节置换术患者术后并发症的影响:基于病历记录的回顾性研究

Public title:

A case records based retrospective study for the effect of Postoperative Analgesia on Postoperative Complications of Hip Arthroplasty

注册题目简写:

English Acronym:

研究课题的正式科学名称:

术后镇痛对髋关节置换术患者术后并发症的影响:基于病历记录的回顾性研究

Scientific title:

A case records based retrospective study for the effect of Postoperative Analgesia on Postoperative Complications of Hip Arthroplasty

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

广东省中医药局科研项目(20191247)

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR1900025103 ; ChiMCTR1900002518

申请注册联系人:

鲁义

研究负责人:

鲁义

Applicant:

Lu Yi

Study leader:

Lu Yi

申请注册联系人电话:

Applicant telephone:

+86 13826495169

研究负责人电话:

Study leader's telephone:

+86 13826495169

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

37363575@qq.com

研究负责人电子邮件:

Study leader's E-mail:

37363575@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

广州市荔湾区珠玑路16号

研究负责人通讯地址:

广州市荔湾区珠玑路16号

Applicant address:

16 Zhuji Road, Guangzhou, Guangdong, China

Study leader's address:

16 Zhuji Road, Guangzhou, Guangdong, China

申请注册联系人邮政编码:

Applicant postcode:

510130

研究负责人邮政编码:

Study leader's postcode:

510130

申请人所在单位:

广州市中医医院

Applicant's institution:

Guangzhou Hospital of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2019NK028

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

广州市中医医院伦理委员会

Name of the ethic committee:

Committee of Guangzhou Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2019/6/6 0:00:00

伦理委员会联系人:

徐雯

Contact Name of the ethic committee:

Xu Wen

伦理委员会联系地址:

广州市中医医院

Contact Address of the ethic committee:

Guangzhou Hospital of Traditional Chinese Medicine, 16 Zhuji Road, Guangzhou, Guangdong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广州市中医医院

Primary sponsor:

Guangzhou Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

广州市荔湾区珠玑路16号

Primary sponsor's address:

16 Zhuji Road, Guangzhou, Guangdong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

广州市中医医院

具体地址:

广州市荔湾区珠玑路16号

Institution
hospital:

Guangzhou Hospital of Traditional Chinese Medicine

Address:

16 Zhuji Road, Guangzhou, Guangdong, China

经费或物资来源:

广东省中医药局科研项目(20191247)

Source(s) of funding:

Scientific Research Project of Guangdong Traditional Chinese Medicine Bureau (20191247)

研究疾病:

髋关节置换术术后并发症

研究疾病代码:

Target disease:

Complications after hip replacement

Target disease code:

研究类型:

Study type:

观察性研究

Observational study

研究设计:

Study design:

析因分组(即根据危险因素或暴露因素分组)

Factorial

研究所处阶段:

Study phase:

其它

Others

研究目的:

探讨术后镇痛对髋关节置换术患者术后并发症的影响

Objectives of Study:

To explore the effect of postoperative analgesia on the complications of hip replacement patients

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)选择本院择期行髋关节置换术(包括半髋关节及全髋关节)老年(年龄≥60)患者; (2)定期到本院复诊,病历资料完善。

Inclusion criteria

(1) Elderly patients (age over 60) who underwent selective hip replacement (including hemiarthroplasty and total hip arthroplasty) were included; (2) there were detailed and completed follow-up data.

排除标准:

(1)有严重心血管系统疾病 (2)有慢性呼吸道疾病如COPD等 (3)有脑卒中、短暂性脑缺血发作病史者 (4)对本研究中使用的镇痛药物过敏史 (5)有药物成瘾史 (6)正在服用抗抑郁药或者镇静药等 (7)有中枢神经系统疾病。

Exclusion criteria:

(1) Severe cardiovascular diseases; (2) Chronic respiratory diseases such as COPD; (3) Stroke and transient ischemic attack; (4) Analgesic allergies used in this study; (5) Drug addiction; (6) Antidepressants or sedatives taken; (7) Central nervous system diseases.

研究实施时间:

Study execute time:

From 2019-08-15

To      2019-08-30

征募观察对象时间:

Recruiting time:

From 2019-08-15

To      2019-08-30

干预措施:

Interventions:

组别:

硬膜外镇痛组

样本量:

400

Group:

PCEA

Sample size:

干预措施:

Nil

干预措施代码:

Intervention:

Nil

Intervention code:

组别:

静脉镇痛组

样本量:

400

Group:

PCIA

Sample size:

干预措施:

Nil

干预措施代码:

Intervention:

Nil

Intervention code:

组别:

口服药物组

样本量:

400

Group:

OA

Sample size:

干预措施:

Nil

干预措施代码:

Intervention:

Nil

Intervention code:

样本总量 Total sample size : 1200

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

广东省

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

广州市中医医院

单位级别:

三级甲等

Institution/hospital:

Guangzhou Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

术前、术中、术后的心跳

指标类型:

主要指标

Outcome:

heart rates before, during and after surgery

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

经济收入

指标类型:

次要指标

Outcome:

Economic Income

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

麻醉持续时间

指标类型:

主要指标

Outcome:

Duration of anesthesia

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术前、术中、术后的血氧饱和度

指标类型:

主要指标

Outcome:

Preoperative, intraoperative and postoperative SPO2

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

麻醉操作

指标类型:

主要指标

Outcome:

Anesthesia operation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术出血

指标类型:

主要指标

Outcome:

Surgical bleeding

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

烟酒嗜好

指标类型:

次要指标

Outcome:

alcohol abuse and smoking

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

一般基本资料

指标类型:

次要指标

Outcome:

General basic information

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

文化程度

指标类型:

次要指标

Outcome:

Degree of Education

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

麻醉用药

指标类型:

主要指标

Outcome:

Anesthetic drugs

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术时间

指标类型:

主要指标

Outcome:

Operation time

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后发生并发症

指标类型:

主要指标

Outcome:

Postoperative complications

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术输血

指标类型:

主要指标

Outcome:

Surgical blood transfusion

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术前、术中、术后的血压

指标类型:

主要指标

Outcome:

Preoperative, intraoperative and postoperative blood pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后3、6、12 个月疼痛值

指标类型:

主要指标

Outcome:

NRS at 3, 6 and 12 months after operation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后6小时到术后3天的疼痛值

指标类型:

主要指标

Outcome:

NRS from 6 hours to 3 days after operation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术种类

指标类型:

主要指标

Outcome:

Types of operation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中术后用药

指标类型:

主要指标

Outcome:

Intraoperative and Postoperative Drug Use

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术前用药

指标类型:

主要指标

Outcome:

Preoperative medication

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 60
Min age years
最大 104
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

N/A

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

盲法:

N/A

Blinding:

N/A

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

文章发表后3个月公开原始数据,读者以及杂志可向通讯作者索取全部原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Three months after the publication of the article, and all the original data can be obtained from corresponding author.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

本研究数据采集采用电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture is adopted in our research.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above